Search Results - F. Vall-Llovera

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    P385: DETECTION OF KMT2A PARTIAL TANDEM DUPLICATIONS IN ACUTE MYELOID LEUKEMIA PATIENTS BY NGS by A. Artigas-Baleri, G. Oñate, A. Brell, J. Esteve, S. Vives, M. Tormo, M. Arnan, A. Garcia, R. Coll, A. Sampol, J. Bargay, F. Vall-llovera, O. Salamero, J. Nomdedéu, M. Pratcorona

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  2. 2

    P565: IMPROVED OUTCOME OF PATIENS WITH ACUTE MYELOID LEUKEMIA HARBORING FLT3 MUTATION IN THE ERA OF TARGETED THERAPY by G. Oñate, M. Pratcorona, A. Garrido, A. Artigas, A. Bataller, M. Tormo, M. Arnan, S. Vives, R. Coll, O. Salamero, F. Vall-Llovera, A. Sampol, A. Garcia, M. Cervera, S. Garcia Avila, J. Bargay, X. Ortin, J. Esteve, J. Sierra

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  3. 3

    P512: PRELIMINARY RESULTS OF VEN-A-QUI STUDY: A PHASE 1-2 TRIAL TO ASSESS THE SAFETY AND EFFICACY OF THE COMBINATION OF AZACITIDINE OR LOW-DOSE CYTARABINE WITH VENETOCLAX AND QUIZA... by J. M. Bergua-Burgues, R. Rodríguez-Veiga, I. Cano, F. Vall-llovera, A. García-Guiñon, J. Gómez-Estruch, M. Colorado, I. Casas-Avilés, J. Esteve-Reyner, M. V. Verdugo, F. Ramos, M. Valero, E. Acuña-Cruz, B. Boluda, L. Torres-Miñana, J. Martínez-López, E. Barragán, R. Ayala, D. Martínez-Cuadrón, P. Montesinos

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  4. 4

    P523: MIDOSTAURIN PLUS INTENSIVE CHEMOTHERAPY IN FLT3 MUTATED AML. “REAL LIFE” DATA VERSUS THE RATIFY STUDY by A. De La Fuente, M. Diaz Beya, P. Beneit, C. Botella, A. Fernandez Moreno, A. Sampol, M. Arnan Sangerman, A. Yeguas Bermejo, M. D. L. L. Amigo, J. Labrador, A. Garcia Guinon, A. Garrido, J. Serrano, S. Vives Polo, M. Garcia Fortes, M. J. Sayas, J. M. Bergua, M. T. Olave, F. Vall LLovera, J. Bargay, M. Pereiro Sanchez, R. Garcia Boyero, A. Diaz Lopez, M. Tormo

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  5. 5

    P508: REAL LIFE EXPERIENCE USING FRONT-LINE CPX-351 FOR THERAPY-RELATED AND AML-MRC: RESULTS FROM THE SPANISH PETHEMA REGISTRY. by T. Bernal, G. Rad, A. de Laiglesia, C. Benavente, A. Garcia Noblejas, D. Garcia Belmonte, R. Riaza, O. Salamero, A. Foncillas, A. Roldán, V. Noriega Concepcion, J. Perez de Oteyza, J. M. Bergua Burgues, S. Lorente de Uña, A. de la Fuente Burguera, M. J. Garcia Perez, J. L. Lopez Lorenzo, P. Martinez, C. Alaez, M. Callejas, C. Martinez Chamorro, J. Rifon Roca, L. Amador Barciela, M. Lopez, K. Gomez Correcha, E. Lavilla Rubiera, M. L. Amigo, F. Vall-Llovera, A. Garrido, M. Garcia Fortes, D. de Miguel Llorente, A. Aules Leonardo, C. Cervero, R. Coll Jorda, M. Perez Encinas, M. Polo Zarzuela, D. Martinez Cuadron, P. Montesinos

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


Search Tools: